ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Crucial Innovations Corp. Signs Management Services Agreement with South African Licensed Medicinal Cannabis Cultivator Cannabudgrow (Pty) Ltd

LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Crucial Innovations Corp., a pioneering medical cannabis company, announced the signing of a Management Services Agreement (MSA) with Cannabudgrow (Pty) Ltd (“CBG”), a licensed cultivator and exporter of medicinal cannabis based in Johannesburg, South Africa.

Under the terms of the agreement, Crucial Innovations will provide CBG with comprehensive management, administrative and strategic services, including oversight of operational, logistical, and business development functions. In return, Crucial Innovations will receive 95% of CBG’s net revenue, following deductions related to regulated cultivation and compliance activities.

“Partnering with Cannabudgrow represents a significant step forward in strengthening our operational footprint and supply chain within one of the world’s most promising emerging medical cannabis markets,” said Crucial Innovations Corp. CEO JP Doran. “CBG’s state-of-the-art indoor cultivation capabilities, combined with CINV’s global expertise in compliance, distribution and product development, position us to deliver safe, consistent and high-quality cannabis-based medicines to patients worldwide.”

Cannabudgrow is fully accredited by the South African Health Products Regulatory Authority (SAHPRA) and operates a GACP- and GMP-certified indoor cultivation facility. Leveraging advanced hydroponic fertigation systems and sustainable LED lighting, the company produces pharmaceutical-grade cannabis designed to meet stringent international quality standards.

This partnership deepens CINV’s operational presence in Africa, enhancing its vertically integrated “seed-to-heal” model that connects cultivation and patient access across global markets. The agreement underscores CINV’s commitment to expanding safe and sustainable access to Cannabis-Based Products for Medicinal Use (CBPMs) while maintaining governance, transparency and ethical operations at every stage.

About Crucial Innovations Corp. (CINV)
Crucial Innovations Corp. (OTC: CINV) is a pioneering medical cannabis company. With a fully licensed network of esteemed cultivators, CINV delivers carefully curated cannabis to the medicinal market in the UK and Europe through its vertically integrated seed-to-sale process. At CINV, we are establishing a new standard for cultivating high-quality cannabis-based products for medicinal use (CBPMs), ensuring consistency, safety, and accessibility across the global supply chain. For more information, please visit www.cinvcorp.com.

About Cannabudgrow (Pty) Ltd
Based in Johannesburg, South Africa, Cannabudgrow (Pty) Ltd is a licensed cultivator and exporter of medicinal cannabis accredited by the South African Health Products Regulatory Authority (SAHPRA). Through precision-controlled indoor cultivation and sustainable production practices, Cannabudgrow produces premium-grade medicinal cannabis meeting international GACP and GMP standards. Learn more at www.cannabudgrow.com.

Media Contact:
Ellen Mellody
cinv@kcsa.com
+1-570-209-2947


Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.